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Research Paper: 
Barriers to Receiving Tissue Plasminogen Activator 
in Patients with Ischemic Stroke 
Background: Cerebrovascular diseases are the second common cause of mortality worldwide. 
The onset of reperfusion in the first 3-4.5 hours is a predictive factor of treatment. 
Objective: The present study investigated barriers to receiving tissue plasminogen activator in 
patients with ischemic stroke.
Methods: This cross-sectional study examined 191 patients with first-ever stroke referring to 
the emergency department of the Persian Gulf Martyrs Hospital of Bushehr City, Iran, in 2016. 
One checklist was completed which included demographic data, history of diseases, knowledge 
of stroke symptoms, and intervals regarding the onset of symptoms to informing emergency, 
informing emergency on arrival at the emergency department of the hospital, and making the 
diagnosis for the patients. The obtained data were analyzed in SPSS v. 19.
Results: Mean±SD age of the patients was 65.92±12.48 years. The majority of patients under 
investigation (55.5%) were female, 63.4% were married, 56% were illiterate and 72.3% resided 
in other districts of Bushehr province. Mean duration between onset of symptoms and arrival 
at emergency department, onset of symptoms and call the emergency service, time of arrival 
at emergency department to perform brain Computer Tomography (CT) scan and also to be 
counseled by a neurologist were 699.66, 195.51, 45.11 and 423.62 minutes, respectively. Finally 
14.6 percent of patients were qualified to be treated with tPA.
Conclusion: The main barrier to timely therapy is a delay in golden time. Therefore, public 
education to promote public awareness could be of great benefit in reducing the referral delay time.
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1. Introduction
troke is caused by the interruption of blood 
flow to the brain (ischemic) or bleeding in-
tracranial (hemorrhagic). According to the 
World Health Organization, stroke is intro-
duced as symptoms of rapid progression of 
localized or diffuse brain dysfunction under 
24 hours. Approximately 80% of stroke cases are isch-
emic [1]. The spread of disability and mortality due to 
stroke has become among the health concerns. It was es-
timated that globally, 15 million individuals encounter 
stroke, annually [2].
Cerebrovascular diseases are the second most common 
cause of death and the sixth leading cause of the burden 
of disease worldwide; they are expected to reach fourth 
place by 2020 [3, 4]. More than 80% of all stroke deaths 
occur in developing countries [3].
Hypertension, hyperlipidemia, a history of the previous 
stroke, smoking, and diabetes are the main risk factors 
for stroke. The symptoms of stroke depend on the affect-
ed part of the brain. The major symptoms are the paraly-
sis of the limbs, ataxia, aphasia, vision disturbance, and 
paresthesia in the body [5].
Fasting Blood Sugar (FBS), lipid profile, Complete 
Blood Count (CBC), Electrocardiogram (ECG), and 
Computer Tomography (CT) scan should be ordered in 
all stroke patients [6]. A brain CT scan is required in every 
patient with a stroke. In the first 12 hours, the stroke may 
not be visible in the CT scan. It is recommended that more 
accurate imaging procedures, such as Magnetic Reso-
nance Imaging (MRI), angiography, and invasive catheter 
angiography be performed only in specific patients [7].
The most common treatment recommended by the 
American Heart Association/American Stroke Associa-
tion (AHA/ASA) in the ischemic type; involves the intra-
venous administration of Tissue Plasminogen Activator 
(tPA). Despite the effect of tPA on improving neurologi-
cal outcomes, most patients with ischemic stroke are not 
treated with tPA. This is because patients are referred for 
treatment after the allotted time (3-4.5 hours) [8]. 
According to a Canadian study, 60% of patients with 
ischemic stroke did not return for antithrombotic therapy 
at the right time; 30% were not transformed by ambu-
lance; only 22% within one hour of receiving to hospital 
underwent brain CT, and just of 8% of patients with isch-
emic stroke received tPA [9].
A study reported that 4 out of 5 Americans drive to a 
stroke central hospital about an hour; however, only 4% of 
them received tPA. The reperfusion of blood flow within 
3-4.5 hours is a predictive factor of effective treatment [10].
The most common barrier to receiving tPA on time is the 
loss of treatment window time due to the delayed arrival 
at the referral center (39%). Other barriers include the re-
luctance and procrastination of physicians (19%) and the 
lack of coordination between emergency medical techni-
cians and the neurology center team (14%). The lack of 
qualified and experienced nurses to provide care to stroke 
patients in 3% of the referral centers was identified as an-
other barrier. The lack of emergency medical technicians 
was reported as another obstacle in 6% of centers. The 
managers of the referral center noted that physicians wait 
until the end of the window period of treatment, expect-
ing the improvement of the patient’s symptoms before 
administering tPA [11]. This study investigated barriers 
to receiving tPA in patients with ischemic stroke.
2. Materials and Methods
The statistical population of the present cross-sectional 
study was all patients referring to Bushehr Persian Gulf 
Martyrs Hospital for the first time in Bushehr City, Iran, 
in 2016 with symptoms of a stroke. The inclusion cri-
teria were ischemic and hemorrhagic stroke according 
to the diagnosis of a neurologist consulting the project, 
stroke for the first time, and living in Bushehr Province, 
Iran. The exclusion criteria were receiving initial isch-
emic treatment in the other provinces, the onset of early 
symptoms of stroke during sleep, and a history of pares-
thesia in the face, paresis, and aphasia which indicate a 
previous stroke. 
The applied data collection form included demograph-
ic data (age, gender, educational level, marital status, & 
the place of residence); questions about time intervals 
(from the onset of symptoms until calling the emergency 
service; referring to the emergency medical technician 
and referring until admission to the emergency room of a 
hospital; time interval from emergency room admission 
until first visiting by the emergency physician; visiting a 
neurologist; preparing tests; performing brain CT scan; 
the interpretation of brain CT scan by a neurologist, & 
the time of starting stroke treatments); risk factors for 
receiving anticoagulants, the knowledge of stroke symp-
toms in patients; the type of stroke; the time of treatment 
for all cases of stroke, and the contraindications of start-
ing tPA. Finally, for all patients who called the emergen-
cy service after starting the onset of symptoms, the times 
were checked with the emergency medical technicians, 
S
Mirzadeh M, et al. Barrier to Receiving rtPA in Stroke. J Inflamm Dis. 2021; 25(1):11-18.
13
Spring 2021. Vol 25. Num 1
and the exact time was noted. The necessary information 
was collected by a neurologist when the patients were 
hospitalized.
The collected data were analyzed in SPSS v. 19, us-
ing the Chi-squared test, Mann-Whitney U test, and 
Kruskal-Wallis test to examine the relationship between 
the studied times and, the qualitative variables of two 
and more states. Quantitative variables were measured 
using descriptive statistics (frequency, relative frequen-
cy, mean, & standard deviation) and the Kolmogorov-
Smirnov test (to determine the normal distribution). The 
significant difference was considered at P<0.05.
3. Results
The Mean±SD age of the examined patients was 
65.92±12.48 years, ranging from 34 to 90 years. The ma-
jority (55.5%) of the study subjects were female, 63.4% 
(121s) were married, and 56% (107) of study partici-
pants were illiterate. Moreover, 138(72.3%) individuals 
lived in the cities of Bushehr Province (Table1).
Unilateral paresthesia (67%) and unilateral paresis 
(48.2%) were the most frequent primary symptoms of 
the study patients. Furthermore, 79.6% of the examined 
patients presented progressing symptoms and 91.6% 
(175) had companions at the time of stroke. Most of the 
explored patients (79.6%) and their companions (69.1%) 
were unaware of the symptoms of a stroke. 
Ninety-Two Percent of strokes were ischemic and 7.3% 
were hemorrhagic. Among ischemic strokes, 72 (40.7%) 
cases had a contraindication to injection tPA. Besides, 
61(31.9%) patients had hypertension (systolic: >185 
mmHg, diastolic: >110 mmHg) at the time of admission 
to the hospital emergency room. More than half (113) of 
the explored patients reported a history of hypertension. 
The history of diabetes and cardiovascular disease was 
also collected (33.5% & 28.3%, respectively).
The Mean±SD time interval between the onset of symp-
toms and referral to the hospital was 699.66±881.68 
minutes. No significant relationship was found between 
the times divided in Table 2 and gender, age, urban and 
rural area of living, educational level, and marital status 
(P>0.05). There was no significant relationship between 
gender, educational level, marital status, age, and place 
of residence, and the awareness of stroke symptoms 
(P>0.05). There was a significant relationship between 
the place of residence and calling the emergency service 
(P=0.013). Finally, 14.6% of the explored patients were 
eligible for receiving tPA.
4. Discussion
This study investigated the barriers to receiving tPA in 
patients with ischemic stroke referring to the Bushehr 
Persian Gulf Martyrs Hospital in 2016. The relevant re-
sults revealed that 35.1% of the examined patients in <3 
hours were referred to the hospital and 20.4% of the ex-
plored patients were aware of the symptoms of a stroke. 
In this study, the mean age of the patients with acute 
stroke was 65.9 years which was in line with those ob-
tained by Hatamabadi et al. (59.7 years) and Daneshfard 
et al. (68.33 years) [12, 13]. The relevant mean age in 
other developing countries is about 65 years. However, 
it seems to be higher in developed countries [14]; this is-
sue indicates that in this study, stroke occurs to younger 
ages.
Most of the examined patients were women (55.5%), 
i.e., consistent with the study of Hatamabadi et al.where 
51.8% of stroke cases were reported in women [12]. In 
the study of Suwanwela et al. the onset of stroke was 
higher in men in all age groups [14]. The data of this 
study were not obtained from data registers and numer-
ous patients were excluded from the study; therefore, it is 
impossible to speak with certainty about this. Addition-
ally, this study was performed on CVA (Cerebrovascular 
accident) patients for the first time, and this difference 
can be justified.
In this study, 51.9% of women were married, i.e., simi-
lar to the results of Ostovar et al. in the cohort study on 
the elderly in Bushehr Province (57.2%) [15].
Fifty-Six Percent of the explored patients were illiterate 
and women had a higher rate (65%). In another study, 
51.8% of the patients were illiterate. It seems that indi-
viduals with lower levels of education are more prone to 
have a stroke [16].
In the present study, the most common early symp-
toms of stroke were hemiparesis (67%) and hemiplegia 
(48.2%). Similar results were obtained by Tallawy and 
associates [16]. As per Daneshfard et al., hemiparesis and 
dysarthria were the most common early symptoms [13].
In the present study, hypertension (59.2%), diabetes 
(33.5%), and ischemic heart disease (28.3%) were the 
most frequent comorbidities in the examined patients 
with stroke, i.e., consist to the results of Daneshfard et 
al.’s study [13]. In a study on stroke in Mashhad, the 
most common underlying disease was hypertension 
[17]. Furthermore, in the study of Ayromlou et al., hy-
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pertension (66.5%) and diabetes (17.7%) were the most 
common comorbidities [18].
About 80% of patients and 70% of their companions 
reported no knowledge of the symptoms of a stroke. 
Aboutalebi et al. reported the average knowledge of in-
dividuals (aged >25-year-olds) as high [19].
The Mean±SD time of the onset of symptoms by refer-
ring to the emergency department was 669.66±881.688 
minutes, i.e., less than that of the study of Hatamabadi et 
al. that equaled 1918±1204 minutes [12]. This reduction 
in time may be because, in the present study, all diag-
nostic and therapeutic measures were performed in one 
hospital; thus, the time from the onset of symptoms to 
hospitalization, diagnosis, and therapeutic measures in 
other hospitals were not wasted. However, approximate-
ly 35.1% of the explored patients referred within 3 hours 
of the onset of symptoms, i.e., consistent with the study 
of Mojdehipanah et al. (67% of the patients referred after 
the first 3 hours of the onset of symptoms). In the study 
of Ayromlou et al., 31.3% of the patients were referred in 
the first 3 hours [18, 20].
In the present study, the Mean±SD time of admitting to 
the emergency room to performing laboratory tests was 
190.718±264.5 minutes, i.e., very high, compared to the 
appropriate time mentioned by ASA/AHA, i.e., 45 min-
utes [21].
The mean time for admitting to the emergency room 
until performing a CT scan was 45.11 minutes, i.e., 25 
minutes longer than the appropriate time set by the ASA/
AHA for a CT scan [21]; therefore, this service is inap-
propriate for the patients. However, in comparison with 
the study of Ayromlou et al. who reported 91 minutes, 
and Hatamabadi et al. who documented 89 minutes for 
the same value, the time was more appropriate in this 
research [12, 18]. This issue highlights the coordina-
tion between the radiology and emergency departments. 
In the present study, the Mean±SD time to refer to the 
emergency room until receiving a physical examination 
by the neurologist was measured as 423.62 406.147 min-
utes, i.e., much higher than that obtained by Hatamabadi 
et al. (100±211 min) [12]. A study reported that tPA in-
jection at the imaging center immediately after perform-
ing CT scan decreased 26 minutes from the time of the 
main protocol (when the patient returns to the emergen-
cy room, then was injected) [22].
Mojdehipanah et al. considered the delay of visiting by 
the neurologist as the most main in the failure of the tPA 
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position [20]. Delayed visits by the neurologist and the 
absence of the neurologist resident in that center can justi-
fy this difference with the present study. Treatment in this 
center is performed by an emergency physician. Hargis et 
al. reported the experience of neurologists and teaching 
centers with residents accelerated tPA injection [11].
The mean time for admitting to the emergency room 
until starting the treatment was 176.96 minutes, i.e., 
similar to 164±320 minutes in the study of Hatamabadi 
and colleagues [12]. However, this rate is very different, 
compared to the appropriate time in ASA/AHA (i.e., one 
hour) [21]. According to Ayromlou et al., the time of 
starting the treatment was 147 minutes [18]. The results 
reveal that in Bushehr City, the time of starting the treat-
ment is longer, despite the shorter diagnosis time (with 
brain CT scan) that requires more coordination in the 
emergency department.
The average time of calling emergency service until 
visiting by emergency medical technicians, is 7 minutes, 
i.e., less than the standard time (8 minutes) for respond-
ing to the emergency missions. A reason for the delay 
in performing the emergency missions is the crowded 
routes. Bushehr City has no significant traffic; thus, the 
mentioned 7 minutes is reasonable.
Given that time plays a critical role in strokes, based on 
the present study data, the time of the onset of the symp-
toms until initiating the treatment (the onset of the symp-
toms until referring to the hospitals, admitting to the 
emergency room until visiting by the neurologist, per-
forming laboratory tests, performing brain CT scan until 
starting treatment) is higher, compared to the standard 
service time recommended by the AHA/ASA. Thus, 
patients lose the golden time and further complications 
have remained. As mentioned in the discussion, delayed 
referring after the onset of symptoms was among the 
main causes of the loss of the golden time (about 70%), 
i.e., associated with the low awareness of stroke symp-
toms in patients and their companions. It is suggested 
that by using the information provided by the physicians 
and public media, such as magazines and television, 
we increase individuals’ awareness about stroke and its 
common symptoms. Proper teaching of the general prac-
titioner who is working in the healthcare centers as the 
first referral place for stroke is also helpful. These issues 
require comprehensive cooperation between the physi-
cians, healthcare centers, and the media.
5. Conclusion
The main barrier to timely therapy is a delay in gold-
en time. Therefore, public education to promote public 
awareness could be of great benefit in reducing the re-
ferral delay time. Delay in the preparation of laboratory 
tests and performing brain CT scans are crucial reasons 
in providing services to patients; thus, it is recommended 
for the patients who could benefit from receiving tPA, 
the necessary coordination between the laboratories and 
imaging centers of the hospital be urgently conducted.
Due to the significance of time in managing patients 
with acute stroke to receive treatment, it is recom-
mended that these patients be immediately referred to 
an emergency physician to be visited by the emergency 
physicians in the shortest possible time.
Table 2. The frequency of the time interval 
Time Interval (Minute) No.* Mean±SD Median Max. Min.
The onset of the symptoms until deciding to go 
to the hospital 191 699.6±881.6 400 4320 30
The onset of symptoms until calling the emer-
gency service 39 195.5±322.1 20 1200 5
Calling the emergency service until visiting by the 
emergency medical technician 39 7.0±4.696 5 30 3
Visiting by the emergency medical technician 
until referring to the hospital 38 20.89±6.821 20 37 9
Admitting in emergency room until visiting by 
neurologist 186 432.6±406.1 305 2550 5
Admitting in emergency room until performing 
laboratory tests 172 190.7±297.65 264.5 1440 32
Admitting in emergency room until performing 
brain CT scan 186 45.11±45.658 30 335 10
Admitting in emergency room until starting tPA 181 176.9±275.2 90 2550 15
* Number
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